Development;A
Brain Patterning;A.01
Patterning of spinal cord, brainstem and cerebellum;A.01.a
Patterning of midbrain, diencephalon and forebrain;A.01.b
Evolution of developmental mechanisms;A.01.c
Neurogenesis and Gliogenesis;A.02
Proliferation: Cell cycle;A.02.a
Proliferation: Molecular mechanisms;A.02.b
Cell lineage;A.02.c
Mechanisms of cell fate;A.02.d
Cell migration: Molecular mechanisms;A.02.e
Cell migration: Cellular dynamics;A.02.f
Neuronal differentiation: Molecular mechanisms;A.02.g
Neuronal differentiation: Response extracellular factors;A.02.h
Glial differentiation;A.02.i
Neuron-glia interactions;A.02.j
Postnatal Neurogenesis;A.03
Postnatal neurogenesis: Temporal and spatial patterns;A.03.a
Postnatal neurogenesis: Molecular mechanisms;A.03.b
Postnatal neurogenesis: Environmental and pharmacological regulation;A.03.c
Stem Cells;A.04
Mechanisms of self-renewal;A.04.a
Epigenetic regulation of stem cells;A.04.b
Induced pluripotent stem cells and models of disease;A.04.c
Neural differentiation of pluripotent stem cells;A.04.d
Axon and Dendrite Development;A.05
Axon growth and guidance: Cytoskeletal dynamics;A.05.a
Axon growth and guidance: Adhesion molecules;A.05.b
Axon growth and guidance: Chemotropic guidance;A.05.c
Axon growth and guidance: Chemotropic signal transduction;A.05.d
Dendritic growth and branching;A.05.e
Synaptogenesis and Activity-Dependent Development;A.06
Synapse formation: PNS;A.06.a
Synapse formation: CNS;A.06.b
Synapse formation: Intracellular trafficking;A.06.c
Activity-dependent changes in connectivity;A.06.d
Activity-dependent growth and remodeling of synapses;A.06.e
Developmental Cell Death;A.07
Developmental cell death: Biological effects;A.07.a
Developmental cell death: Neurotrophins and other trophic factors;A.07.b
Development of Motor, Sensory and Limbic Systems;A.08
Motor system;A.08.a
Visual system;A.08.b
Auditory and vestibular systems;A.08.c
Somatosensory system;A.08.d
Olfactory and taste systems;A.08.e
Limbic system;A.08.f
Transplantation and Regeneration;A.09
Transplantation;A.09.a
Regeneration: PNS;A.09.b
Regeneration: CNS;A.09.c
Evolution of Developmental Mechanisms;A.10
Evolution of developmental mechanisms;A.10.a
Neural Excitability, Synapses, and Glia: Cellular Mechanisms;B
Neurotransmitters and Signaling Molecules;B.01
Amino acids: Intracellular signaling cascades;B.01.a
Monoamines: Anatomical localization;B.01.b
Monoamines: Intracellular signaling cascades;B.01.c
Acetylcholine;B.01.d
Retrograde messengers: Endocannabinoids;B.01.e
Retrograde messengers: Nitric oxide and other gases;B.01.f
Opiates and other neuropeptides;B.01.g
Neurotrophins: Synthesis, processing, and release;B.01.h
Neurotrophins: Intracellular signaling cascades;B.01.i
Invertebrate neurotransmitters;B.01.j
Cytokines: Expression, regulation, and function;B.01.k
Ligand Gated Ion Channels;B.02
Nicotinic acetylcholine receptors in brain: Physiology and function;B.02.a
Nicotinic acetylcholine receptors: Trafficking and signaling;B.02.b
Nicotinic acetylcholine receptors: Regulation and function;B.02.c
NMDA receptors: Localization and trafficking;B.02.d
NMDA receptors: Physiology;B.02.e
Non-NMDA glutamate receptors: Structure and trafficking;B.02.f
Non-NMDA glutamate receptors: Physiology;B.02.g
GABA(A) receptors: Structure and trafficking;B.02.h
GABA(A) receptors: Physiology;B.02.i
Glycine receptors;B.02.j
TRP channels;B.02.k
Other;B.02.l
G-Protein Linked Receptors;B.03
Muscarinic receptors;B.03.a
Metabotropic glutamate receptors;B.03.b
GABA(B) receptors;B.03.c
Serotonin receptors;B.03.d
Catecholamine receptors;B.03.e
Peptide receptors;B.03.f
Opioid receptors;B.03.g
Purine receptors;B.03.h
GPCR trafficking;B.03.i
Other;B.03.j
Ion Channels;B.04
Sodium channels: Physiology;B.04.a
Calcium channels: Physiology;B.04.b
Potassium channels: Physiology;B.04.c
Potassium channels: Calcium activated;B.04.d
Ion channels and disease;B.04.e
HCN and non-selective cation channels;B.04.f
Ion channel trafficking;B.04.g
Other;B.04.h
Transporters;B.05
Glutamate;B.05.a
Monoamine;B.05.b
Dopamine transporters;B.05.c
Other;B.05.d
Neurotransmitter Release;B.06
Docking and fusion;B.06.a
Vesicle recycling and biogenesis;B.06.b
Calcium dependence;B.06.c
Synaptic Transmission;B.07
Presynaptic organization and structure;B.07.a
Postsynaptic organization and structure;B.07.b
Synaptic integration;B.07.c
Electrical synapses and gap junctions;B.07.d
Modulation: Peptides and amines;B.07.e
Modulation: ACh, amino acids and GABA;B.07.f
Modulation: Mechanisms of action;B.07.g
Modulation: Pharmacology;B.07.h
Synaptic Plasticity;B.08
Short-term plasticity;B.08.a
LTP: Kinases and intracellular signaling;B.08.b
LTP: Physiology and behavior;B.08.c
LTP: Presynaptic mechanisms;B.08.d
LTP: Postsynaptic mechanisms;B.08.e
Long-term depression (LTD);B.08.f
Spike-timing dependent plasticity;B.08.g
Homeostatic plasticity;B.08.h
Structural plasticity;B.08.i
Transcription and translation in plasticity;B.08.j
Other;B.08.k
Network Interactions;B.09
Signal propagation;B.09.a
Oscillations and synchrony: Unit studies;B.09.b
Oscillations and synchrony: EEG studies;B.09.c
Oscillations and synchrony: Other;B.09.d
Intrinsic Membrane Properties;B.10
Neural oscillators and activity-dependent plasticity of intrinsic membrane properties;B.10.a
Modulation of neuronal firing properties;B.10.b
Dendritic excitability and synaptic integration;B.10.c
Glia-Neuron Interactions;B.11
Synapses;B.11.a
Cell biology and signaling: Astrocytes;B.11.b
Cell biology and signaling: Microglia;B.11.c
Cell biology and signaling: Oligodendrocytes;B.11.d
In vivo approaches;B.11.e
Disorders of the Nervous System;C
Brain Wellness;C.01
Brain wellness;C.01.a
Translational Mechanisms;C.02
Channelopathies: Functional consequences;C.02.a
Synaptopathies: Functional consequences;C.02.b
Glial mechanisms;C.02.c
Neuro-immunology;C.02.d
Neuro-endocrinology;C.02.e
Neuro-vascular coupling;C.02.f
Metabolism and energetics;C.02.g
Alzheimer's Disease and Other Dementias;C.03
Physiological functions and processing of APP and APP metabolites;C.03.a
Abeta assembly and deposition;C.03.b
APP/Abeta: Animal models;C.03.c
APP/Abeta: Cellular models;C.03.d
Tau: Animal models;C.03.e
Tau: Related cellular models;C.03.f
Tau: Biochemistry;C.03.g
APP-Abeta/tau models;C.03.h
In vivo Abeta toxicity;C.03.i
In vitro Abeta toxicity;C.03.j
Abeta oligomers;C.03.k
Alzheimer's disease: In vivo therapeutics;C.03.l
Alzheimer's disease: In vitro therapeutics;C.03.m
Alzheimer's disease: Neuroinflammation;C.03.n
Alzheimers disease: Immune mechanisms;C.03.o
Beta and gamma secretase, BACE and presenilin;C.03.p
Abeta metabolism;C.03.q
Anti-Abeta treatments;C.03.r
ApoE and cholesterol;C.03.s
Tau and non-Alzheimers dementia;C.03.t
Abnormal pathological proteins excluding tau and Abeta;C.03.u
Cognitive function;C.03.v
Neuropharmacology and neurotransmitters;C.03.w
Synaptic biology related to Alzheimers disease;C.03.x
Genetics and functional genomics;C.03.y
Imaging and biomarkers;C.03.z
Parkinsons Disease;C.04
Genetic determinants;C.04.a
Human studies;C.04.b
Degeneration models;C.04.c
Transgenic and related mouse models;C.04.d
Rat and mouse toxin and behavior models;C.04.e
Mechanisms and degeneration treatment;C.04.f
Clinical therapies;C.04.g
Animal therapies;C.04.h
Cellular mechanisms;C.04.i
Circuit mechanisms;C.04.j
Dopamine and non-dopamine pathways;C.04.k
Mechanisms of cell death and dysfunction;C.04.l
Neuroprotective mechanisms;C.04.m
Gene and neurotoxin: Animal and human studies;C.04.n
Neurodegenerative Disorders and Movement Disorders;C.05
Huntington's disease: Mechanisms;C.05.a
Huntington's disease: Animal models;C.05.b
Huntington's disease: Other;C.05.c
Repeat expansion diseases: Non-Huntingtons disease;C.05.d
Ataxias;C.05.e
Motor neuron disease: Mechanisms;C.05.f
Motor neuron disease: Animal models;C.05.g
Motor neuron disease: Therapeutics;C.05.h
Prion diseases;C.05.i
Dystonia;C.05.j
Other neurodegenerative disorders;C.05.k
Neuromuscular diseases;C.05.l
Aging;;C.06
Molecular studies;C.06.a
Physiological and molecular correlates;C.06.b
Oxidative stress;C.06.c
Developmental Disorders;C.07
Autism: Genetic and animal models;C.07.a
Autism: Environment and pathology;C.07.b
Autism: Physiology and systems;C.07.c
Developmental disorders affecting brain size: Lissencephaly, microcephaly and macrocephaly;C.07.d
Rett syndrome;C.07.e
Fragile X;C.07.f
Down syndrome;C.07.g
Angelman and other developmental disorders;C.07.h
Non-syndromic forms of general cognitive dysfunction;C.07.i
ADHD, SLI, dyslexia and other specific disorders of neurobehavior;C.07.j
Animal models and mechanisms;C.07.k
Epilepsy;C.08
Genetics;C.08.a
Channels;C.08.b
GABAergic neurotransmission;C.08.c
Glutametergic neurotransmission;C.08.d
Synaptic mechanisms;C.08.e
Networks;C.08.f
Post-seizure modifications;C.08.g
In vivo and behavior;C.08.h
Predisposing factors;C.08.i
Animal Models;C.08.j
Anticonvulsant and antipileptic therapies;C.08.k
Human Studies;C.08.l
Behavioral disorders;C.08.m
Ischemia;C.09
Cellular mechanisms;C.09.a
Molecular mechanisms;C.09.b
Neurovascular unit;C.09.c
Ischemia: Perinatal;C.09.d
Ischemia: Recovery;C.09.e
Ischemia: Animal Models;C.09.f
Oxidative stress;C.09.g
Inflammation;C.09.h
Neuroprotection;C.09.i
Animal models of ischemic and hemorrhagic stroke;C.09.j
Cell based therapies;C.09.k
Models of ischemia and stroke;C.09.l
Human and translational studies;C.09.m
Demyelinating Disorders;C.10
Molecular and cellular mechanisms;C.10.a
Therapeutics;C.10.b
Human and animal studies;C.10.c
Trauma;C.11
Brain: Cellular and molecular mechanisms;C.11.a
Brain: Animal models and human studies;C.11.b
Brain: Therapeutic strategies;C.11.c
Spinal cord: Cellular and molecular mechanisms;C.11.d
Spinal cord: Animal models and human studies;C.11.e
Spinal cord: Therapeutic strategies;C.11.f
Peripheral nerve trauma, crush and toxic injury;C.11.g
Neurotoxicity, Inflammation, and Neuroprotection;C.12
Cell death mechanisms: Mitochondria;C.12.a
Cell death mechanisms: Excitotoxicity and calcium;C.12.b
Cell death mechanisms: Oxidative stress;C.12.c
Cell death mechanisms: DNA repair;C.12.d
Cell death mechanisms: Apoptosis and caspases;C.12.e
Toxic metabolic effects and disorders;C.12.f
Neuroprotective mechanisms: Oxidative stress;C.12.g
Neuroprotective mechanisms: Estrogens and other hormones;C.12.h
Neuroprotective mechanisms: Stem cells and glia;C.12.i
Neuroprotective mechanisms: Apoptosis and caspases;C.12.j
Neurotoxicity and neurodegeneration;C.12.k
Neurotoxicity and inflammation: Stem cells and glia;C.12.l
Neuroinflammation: Cellular and molecular mechanisms;C.12.m
Neuroinflammation: Neurodegeneration;C.12.n
Neuroinflammation: Animal models;C.12.o
Neuroinflammation: HIV and infections;C.12.p
Neuroinflammation: Human studies;C.12.q
Neuro-Oncology;C.13
Neuro-oncology;C.13.a
Sensory Disorders;C.14
Visual and auditory;C.14.a
Somatosensory and pain;C.14.b
Gene Therapy;C.15
Gene therapy;C.15.a
Schizophrenia and Bi-polar Disorder;C.16
Neuropathology;C.16.a
Genetics and genomics;C.16.b
Human studies;C.16.c
Animal models;C.16.d
Mutant animal models;C.16.e
Biochemical studies;C.16.f
Experimental therapeutics: Preclinical studies;C.16.g
Experimental therapeutics: Behavior models;C.16.h
Cognitive, Emotional, and Behavioral State Disorders;C.17
Mood disorders: Human post mortem studies;C.17.a
Mood disorders: Human biomarkers and treatment studies;C.17.b
Mood disorders: Animal models;C.17.c
Mood disorders: Mutant animal models;C.17.d
Mood disorders: Experimental therapeutics, preclinical studies;C.17.e
Mood disorders: Experimental therapeutics, behavioral models;C.17.f
Anxiety disorders: Human biomarkers and treatment studies;C.17.g
Anxiety disorders: Animal models;C.17.h
Anxiety disorders: Experimental therapeutics;C.17.i
Drugs of Abuse and Addiction;C.18
Alcohol: Intake and preference;C.18.a
Alcohol: Tolerance, dependence and withdrawal;C.18.b
Alcohol: Developmental effects;C.18.c
Alcohol: Behavioral effects;C.18.d
Alcohol: Neural mechanisms;C.18.e
Nicotine: Neural mechanisms of addiction;C.18.f
Nicotine: Reinforcement, seeking and reinstatement;C.18.g
Nicotine: Developmental effects;C.18.h
Cocaine: Neural mechanisms of addiction;C.18.i
Cocaine reinforcement, seeking and reinstatement;C.18.j
Amphetamine and related drugs: Neural mechanisms of addiction;C.18.k
Amphetamine and related drugs: Reinforcement, seeking and reinstatement;C.18.l
Cocaine, amphetamine and related drugs: Toxicity;C.18.m
Cocaine, amphetamine and related drugs: Developmental effects;C.18.n
Opioids: Neural mechanisms of addiction;C.18.o
Opioid reinforcement, seeking and reinstatement;C.18.p
Opioids: Tolerance, dependence and withdrawal;C.18.q
Opioids: Developmental effects;C.18.r
Opioids: Translational and clinical studies;C.18.s
Cannabinoids: Neural mechanisms and addiction;C.18.t
Cannabinoid reinforcement, seeking and reinstatement;C.18.u
Cannabinoids: Tolerance, dependence and withdrawal;C.18.v
Cannabinoids: Developmental effects;C.18.w
Sedative hypnotics and anxiolytics;C.18.x
Addiction: Genetics;C.18.y
Addiction treatment: Translational and clinical studies;C.18.z
Learning, memory, dependence and addiction;C.18.aa
Neural plasticity, dependence and addiction;C.18.bb
Addiction: Behavioral pharmacology;C.18.cc
Behavioral Pharmacology;C.19
Neuropeptides and behavior;C.19.a
Monoamines and behavior: Serotonin and histamine;C.19.b
Monoamines and behavior: Dopamine and norepinephrine;C.19.c
CNS depressants;C.19.d
Drug Discovery and Development;C.20
Affective disorders and schizophrenia;C.20.a
Epilepsy;C.20.b
Neurodegenerative diseases (AD, PD, MS, stroke);C.20.c
Pain, headache and migraine;C.20.d
Biotherapeutics: Gene and stem cell therapies;C.20.e
Drug delivery;C.20.f
Generic drugs and formulations;C.20.g
Perinatal Brain Injury;C.21
Acute therapy: Pharmacological approaches;C.21.a
Acute therapy: Non-pharmacological approaches;C.21.b
Stroke Recovery;C.22
Stroke recovery: Pharmacological approaches to therapy;C.22.a
Stroke recovery: Non-pharmacological approaches to therapy;C.22.b
Stroke imaging and diagnostic studies;C.22.c
Sensory and Motor Systems;D
Chemical Senses;D.01
Olfactory receptor cells and transduction;D.01.a
Olfactory coding: Second order regions (olfactory bulb and antennal lobe);D.01.b
Olfactory coding: Higher-order regions and integrative studies;D.01.c
Olfaction: Central circuits and neurotransmitters;D.01.d
Olfaction: Behavior, perception, and its relation to neurophysiology;D.01.e
Taste;D.01.f
Auditory;D.02
Mechanoreceptors and cochlea;D.02.a
Auditory processing: Sound localization and binaural interactions;D.02.b
Auditory processing: Temporal, frequency, and spectral processing;D.02.c
Auditory processing: Vocalizations and natural sounds;D.02.d
Auditory processing: Circuits, synapses, neurotransmitters;D.02.e
Auditory processing: Adaptation, learning, memory;D.02.f
Auditory processing: Neural coding, experiment and theory;D.02.g
Auditory processing: Perception, cognition, and action;D.02.h
Multisensory;D.03
Cross-modal processing: Spatial factors;D.03.a
Cross-modal processing: Temporal factors;D.03.b
Cross-modal processing: Neural circuitry and connections;D.03.c
Cross-modal processing: Development;D.03.d
Vision;D.04
Retina: Photoreceptors;D.04.a
Retinal circuitry: Receptors;D.04.b
Retinal circuitry: Synaptic interactions;D.04.c
Retinal circuitry: Coding mechanisms;D.04.d
Subcortical visual pathways;D.04.e
Striate cortex: Local circuitry;D.04.f
Striate cortex: Functional organization;D.04.g
Striate cortex: Neural coding;D.04.h
Striate cortex: Response properties;D.04.i
Striate cortex: Plasticity;D.04.j
Extrastriate cortex: Organization and circuitry;D.04.k
Extrastriate cortex: Functional organization;D.04.l
Extrastriate cortex and subcortical structures: Neural coding;D.04.m
Processing of contrast;D.04.n
Processing of orientation;D.04.o
Processing of form and color;D.04.p
Visual motion: Neural mechanisms;D.04.q
Visual motion: Behavioral studies;D.04.r
Representation of objects;D.04.s
Representation of faces and bodies;D.04.t
Visual learning and categorization;D.04.u
Binocular vision, depth, and stereo;D.04.v
Spatial attention;D.04.w
Feature-based attention;D.04.x
Attention: Cognitive and behavioral studies;D.04.y
Visual cognition: Memory;D.04.z
Visual cognition: Decision making;D.04.aa
Visual Sensorimotor Processing;D.05
Eye movements and perception;D.05.a
Spatial memory;D.05.b
Sensorimotor transformation: Behavior and whole animal;D.05.c
Sensorimotor transformation: Higher order functional organization;D.05.d
Sensorimotor transformation: Neurophysiology;D.05.e
Spatial memory and eye-hand coordination;D.05.f
Visually guided reaching;D.05.g
Eye Movements;D.06
Brainstem, cerebellum and muscles;D.06.a
Cortex and thalamus;D.06.b
Eye and head control;D.06.c
Eye movements: Saccades;D.06.d
Eye movements: Perception and neural mechanisms;D.06.e
Pursuit;D.06.f
Vestibular;D.07
Hair cells, end organs, and nerve;D.07.a
Central physiology and anatomy;D.07.b
Vestibulo-ocular reflex;D.07.c
Perception, posture, and spatial orientation;D.07.d
Pain;D.08
Pain transduction: TRP channels;D.08.a
Pain transduction: Non-TRP channels;D.08.b
Pain transduction: Non-channel molecules;D.08.c
Nociceptors: Molecular and pharmacological studies;D.08.d
Nociceptors: Anatomical and physiological studies;D.08.e
Spinal cord processing: Anatomy and physiology;D.08.f
Spinal cord processing: Pharmacology;D.08.g
Trigeminal processing;D.08.h
Thalamic and cortical processing;D.08.i
Descending modulation: Molecular and pharmacological studies;D.08.j
Descending modulation: Anatomical and physiological studies;D.08.k
Psychophysics and behavior;D.08.l
Treatments for persistent pain;D.08.m
Pain models: Pharmacology;D.08.n
Pain models: Behavior;D.08.o
Pain models: Physiology;D.08.p
Inflammatory pain: Inflammatory mediators;D.08.q
Inflammatory pain: Nociceptor sensitization;D.08.r
Inflammatory pain: Central sensitization;D.08.s
Mechanisms of neuropathic pain: Ion channels;D.08.t
Mechanisms of neuropathic pain: Glia;D.08.u
Mechanisms of neuropathic pain: Inflammatory mediators;D.08.v
Mechanisms of neuropathic pain: Neurotrophins and neurotransmitters;D.08.w
Mechanisms of neuropathic pain: Signaling pathways and models;D.08.x
Visceral pain;D.08.y
Musculoskeletal pain;D.08.z
Pain imaging and perception;D.08.aa
Opioid receptor pharmacology and signaling mechanisms;D.08.bb
Opioid in vivo pharmacology;D.08.cc
Other analgesics;D.08.dd
Tactile/Somatosensory;D.09
Receptors and cellular and molecular mechanisms of transduction;D.09.a
Plasticity and reorganization;D.09.b
Local cortical circuits;D.09.c
Functional organization;D.09.d
Thalamocortical processes;D.09.e
Stimulus feature receptive fields and response properties;D.09.f
Stimulus feature neural coding;D.09.g
Functional studies;D.09.h
Spinal Cord Injury and Plasticity;D.10
Spinal cord injury: Posture and locomotion;D.10.a
Spinal cord injury: Recovery;D.10.b
Spinal cord injury: Training, rehabilitation, and repair;D.10.c
Plasticity: Neurophysiology;D.10.d
Plasticity: Neurotransmitters and molecular biology;D.10.e
Vertebrate and Invertebrate Rhythmic Motor Pattern Generation;D.11
Cellular properties: Interneurons and motor neurons;D.11.a
Connectivity;D.11.b
Neuromodulation;D.11.c
Afferent control;D.11.d
Descending control;D.11.e
Models;D.11.f
Kinematics and EMG;D.12
Reflexes and reflex modulation;D.12.a
Reflexes after stroke, injury, and disease;D.12.b
Motor Neurons and Muscle;D.13
Motor neurons: Activity; sensory and central control; exercise, injury and disease;D.13.a
Motor neurons: Development, identification, intrinsic properties, modulation;D.13.b
Motor unit recordings, kinematics, and EMG;D.13.c
Motorneuron-muscle interface;D.13.d
Muscle physiology and biochemistry;D.13.e
Cerebellum;D.14
Cerebellum: Cortex and nuclei;D.14.a
Cerebellum: Plasticity and climbing fibers;D.14.b
Cerebellum: Human studies;D.14.c
Basal Ganglia;D.15
Transmitters and neuromodulation;D.15.a
Cellular physiology;D.15.b
Small networks and plasticity;D.15.c
Systems physiology;D.15.d
Systems behavior;D.15.e
Posture and Gait;D.16
Posture and gait: Kinematics, muscle activity, exercise and fatique, biomechanics;D.16.a
Posture and gait: Afferent control;D.16.b
Posture and gait: Higher order control, multi-task integration, theory;D.16.c
Posture and gait: Aging, injury, and disease;D.16.d
Voluntary Movements;D.17
Finger and grasp control: Normal human behavior;D.17.a
Finger and grasp control: Age, pathology, and physiology;D.17.b
Reaching control: Action and sensation;D.17.c
Reaching control: Movement selection and strategy;D.17.d
Reaching control: Motor learning;D.17.e
Interlimb and bimanual control;D.17.f
Stroke, damage, or disease: Mechanisms of abnormal movement;D.17.g
Stroke, damage, or disease: Assessment and treatment;D.17.h
Cortical planning and execution: Behavior;D.17.i
Cortical planning and execution: Neurophysiology;D.17.j
Cortical planning and execution: Neuroimaging;D.17.k
Oral motor and speech;D.17.l
Plasticity;D.17.m
Brain-Machine Interface;D.18
Neurophysiology: Non-invasive mechanisms;D.18.a
Neurophysiology: Implanted electrodes, other direct interactions with neurons;D.18.b
Neuroprosthetics: Control of real and artificial arm, hand, other grasping devices;D.18.c
Neuroprosthetics: Control of real and artificial leg, trunk, other postural/locomotory devices;D.18.d
Neuroprosthetics: Other motor sensory interfaces, for example artificial vision;D.18.e
Tissue response and analytical methods;D.18.f
Comparative Anatomy and Evolution;D.19
Comparative anatomy;D.19.a
Evolution;D.19.b
Integrative Systems: Neuroendocrinology, Neuroimmunology and Homeostatic Challenge;E
Neuroendocrine Processes;E.01
HPG axis: GnRH cells and gonadotrophins;E.01.a
HPG axis: Neural control;E.01.b
HPA axis: Steroid control;E.01.c
Neurohypophyseal hormones;E.01.d
Neuroendocrine anatomy and physiology;E.01.e
Neurosteroids;E.01.f
Steroids and plasticity;E.01.g
Sexual differentiation;E.01.h
Neuroimmunology;E.02
Regulating systems;E.02.a
Behavioral effects;E.02.b
Behavioral Neuroendocrinology;E.03
Sexual behavior: Steroid control;E.03.a
Sexual behavior: Neural control;E.03.b
Sexual behavior: Pharmacology, experience, environment;E.03.c
Parental behavior;E.03.d
Social behavior;E.03.e
Defensive behavior and aggression;E.03.f
Hormones and cognition;E.03.g
Autonomic Regulation;E.04
Cardiovascular regulation;E.04.a
Respiratory regulation: Central respiratory chemoreception;E.04.b
Respiratory regulation: Respiratory rhythm and pattern generation;E.04.c
Respiratory regulation: Hypoxia and obstructive sleep apnea;E.04.d
Thermoregulation;E.04.e
Gastrointestinal, renal/urinary, and reproductive regulation;E.04.f
Stress and the Brain;E.05
Stress and neuroimmunology;E.05.a
Cellular actions of stress;E.05.b
Early life experience;E.05.c
Stress-modulated pathways: Cortex, hippocampus, and striatum;E.05.d
Stress-modulated pathways: Hypothalamus, amygdala, and bed nucleus;E.05.e
Stress-modulated pathways: Brainstem, spinal and peripheral;E.05.f
Stress-modulated pathways: Other;E.05.g
Stress and cognition;E.05.h
Thirst and Water Balance;E.06
Thirst and water balance;E.06.a
Food Intake and Energy Balance;E.07
Integration of peripheral signals: Regulators;E.07.a
Integration of peripheral signals: Systems;E.07.b
Central pathways: Anatomy and development;E.07.c
Neuropeptide regulators;E.07.d
Monoamine regulators;E.07.e
Amino acids and other regulators;E.07.f
Biological Rhythms and Sleep;E.08
Entrainment and phase shifts;E.08.a
Molecular biology and physiology of clocks;E.08.b
Sleep: Molecular, cellular, and pharmacology;E.08.c
Sleep: Regulators;E.08.d
Sleep: Systems and behavior;E.08.e
SCN anatomy, physiology, neurochemistry;E.08.f
Brain Blood Flow, Metabolism, and Homeostasis;E.09
Energy metabolism;E.09.a
Blood flow;E.09.b
Blood brain barrier;E.09.c
Hypoxia/hyperoxia;E.09.d
Functional imaging;E.09.e
Cognition and Behavior;F
Human Cognition and Behavior;F.01
Perception and imagery;F.01.a
Human learning: Perceptual and spatial learning;F.01.b
Human learning: Motor and sequence learning;F.01.c
Human learning: Feedback, reinforcement and reward;F.01.d
Human long-term memory: Medial temporal lobe;F.01.e
Human long-term memory: Retrieval;F.01.f
Human long-term memory: Encoding;F.01.g
Human long-Term memory: Encoding-retrieval interactions;F.01.h
Functional mechanisms of attention;F.01.i
Attentional networks;F.01.j
Disorders of attention;F.01.k
Executive function;F.01.l
Language;F.01.m
Emotion;F.01.n
Working memory;F.01.o
Decision making and reasoning;F.01.p
Cognitive development;F.01.q
Cognitive aging;F.01.r
Individual differences;F.01.s
Timing and temporal processing;F.01.t
Social cognition;F.01.u
Animal Cognition and Behavior;F.02
Functional mechanisms of attention;F.02.a
Pharmacology for attention;F.02.b
Executive function: Learning and memory;F.02.c
Executive function: Network activity;F.02.d
Executive function: Decision making;F.02.e
Executive function: Disorders;F.02.f
Timing and temporal processing;F.02.g
Cognitive learning and memory systems;F.02.h
Prefrontal/striatal systems: Anatomy/histology;F.02.i
Prefrontal/striatal systems: Molecular mechanisms;F.02.j
Prefrontal/striatal systems: Signaling pathways;F.02.k
Prefrontal/striatal systems: Circuit/systems physiology;F.02.l
Prefrontal/striatal systems: Circuit/systems pharmacology;F.02.m
Medial temporal lobe systems: Anatomy/histology;F.02.n
Medial temporal lobe systems: Molecular mechanisms;F.02.o
Medial temporal lobe systems: Signaling pathways;F.02.p
Medial temporal lobe systems: Circuit/systems physiology;F.02.q
Medial temporal lobe systems: Circuit/systems pharmacology;F.02.r
Associative, nonassociative, and skill learning;F.02.s
Fear and aversive learning and memory: Signaling pathways for acquisition;F.02.t
Fear and aversive learning and memory: Molecular biology of acquisition;F.02.u
Fear and aversive learning and memory: Modulation;F.02.v
Fear and aversive learning and memory: Conditioned aversion circuits and development;F.02.w
Fear and aversive learning and memory: Extinction;F.02.x
Fear and aversive learning and memory: Amygdala and extended amygdala circuits;F.02.y
Fear and aversive learning and memory: Hippocampal related circuits;F.02.z
Fear and aversive learning and memory: Entorhinal cortex;F.02.aa
Appetitive and incentive learning and memory;F.02.bb
Memory consolidation and reconsolidation: Behavior;F.02.cc
Memory consolidation and reconsolidation: Neural mechanisms;F.02.dd
Memory consolidation and reconsolidation: Molecular mechanisms;F.02.ee
Learning and memory: Cortical and hippocampal circuits;F.02.ff
Learning and memory: Gamma and theta activity;F.02.gg
Learning and memory: Aging;F.02.hh
Learning and memory: Genes, signaling and neurogenesis;F.02.ii
Learning and memory: Physiology;F.02.jj
Learning and memory: Pharmacology;F.02.kk
Learning and memory Invertebrates;F.02.ll
Aging;F.02.mm
Motivation and Emotion;F.03
Reward: Dopamine;F.03.a
Reward: Motivational mechanisms;F.03.b
Reward: Neuropharmacology;F.03.c
Reward: Ultrasonic vocalization;F.03.d
Decision making: Neurocircuitry;F.03.e
Decision making: Neuropharmacology;F.03.f
Motivation and emotions: Neurocircuitry;F.03.g
Motivation and emotions: Fear, anxiety, and pain;F.03.h
Motivation and emotions: Reward;F.03.i
Motivation and emotions: Negative emotional states;F.03.j
Motivation and emotions: Risk taking;F.03.k
Motivation and emotions: Social communication;F.03.l
Motivation and emotions: Information processing;F.03.m
Neuroethology;F.04
Sensory systems;F.04.a
Motor systems;F.04.b
Vocal/social communication;F.04.c
Seasonal and sex differences;F.04.d
Other;F.04.e
Novel Methods and Technology Development;G
Molecular, Biochemical, and Genetic Techniques;G.01
Molecular, biochemical, and genetic techniques;G.01.a
Genomics, Proteomics, and Systems Biology;G.02
Genomics, proteomics, and systems biology;G.02.a
Staining, Tracing, and Imaging Techniques;G.03
Staining, tracing, and imaging techniques;G.03.a
Physiological Methods;G.04
Optical methods;G.04.a
Optogenetics;G.04.b
Electrophysiology;G.04.c
Novel assays;G.04.d
Software;G.04.e
Bioinformatics;G.05
Bioinformatics;G.05.a
Computation, Modeling, and Simulation;G.06
Computation, modeling, and simulation;G.06.a
Data Analysis and Statistics;G.07
Data analysis and statistics;G.07.a
History, Teaching, Public Awareness, and Societal Impacts in Neuroscience;H
History of Neuroscience;H.01
History of neuroscience;H.01.a
Teaching of Neuroscience;H.02
K-12;H.02.a
College, graduate, and professional;H.02.b
Public Awareness of Neuroscience;H.03
Educational events;H.03.a
Outreach activities;H.03.b
Ethical and Policy Issues in Neuroscience;H.04
Ethical and policy issues in neuroscience;H.04.a
